Stock Guru Profile HSXI
HealthSonix provides a solution to a modern day quest: living and working free from pain. HealthSonix has now provided a home solution.
A new Health Sonix product, enSonix@home, is has been registered and cleared with the United States, Food and Drug Administration (FDA). The enSonix@home personal treatment device has been designated as a class one device, the safest classification for medical devices with the FDA. It is indicated for pain reduction and muscle relaxation.
“We have achieved another significant milestone in our business development by registering enSonix@home with the FDA. enSonix@home is an exciting new product that will appeal to a wide patient base. Over 350,000,000 people world wide suffer from arthritis pain. With this new medical device, we offer affordable, effective arthritis pain relief with no known side effects. Patients can use it in the comfort of their own homes or while traveling,” said Dieter Doederlein, Vice President of Corporate Development. “Arthritis is still the number one cause of chronic pain in North America and our breakthrough medical technology is very timely with the aging of the population.” The product is available in limited quantities presently and will be launched commercially in first quarter of 2007.
enSonix@home will retail for $150 and will initially be marketed directly to consumers through direct response infomercials and direct to consumer advertising through AARP and Arthritis Today consumer publications.
The sound pressure waves generated by the enSonix@home medical device are believed to work in three ways: they stimulate mechanoreceptors in the skin, which in turn communicate with the brain and block pain messages from getting through (gate control theory of pain); they create an exercise effect in the muscles, which encourages the production and release of endorphins, the body’s natural pain killers; and they increase blood circulation.
Stay tuned for more on this company that provides relief to an achey body!
Sources:
HealthSonix Inc.
14252 Culver Drive
Suite 107
Irvine CA 92604-0317
Tel: (949)417-8880
Fax: (949)271-3760
www.HealthSonix.com
About HealthSonix Inc.: HealthSonix Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) is a publicly traded medical technology company. The Company’s core offerings are based on proprietary, patent pending medical technologies that use sound pressure waves to administer sub-sensory micro vibration to the human body. Precisely formatted low frequency sound pressure waves are 80% effective in treating the pain of many diseases, particularly arthritis. All treatments and products are safe, non-invasive, drug free, and have no known side effects.
Forward Loooking Statement: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.
�
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .
Disclosure: Pentony Enterprises LLC was compensated $12,500 from a non-controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
�
